May 2021

As many others experienced with the COVID-19 pandemic, the United States Food and Drug Administration’s (FDA’s) Center for Drug…

In March 2021, the Federal Trade Commission (FTC) announced a review of its approach to biopharmaceutical mergers and…

Earlier this year, the United States Food and Drug Administration (FDA) reopened a proposed study to understand the way drug names…

On April 1, 2021, NRS 449 became law, which established new standards for anti-discrimination in health care in the state of…

RAND researchers recently published a research brief that found that prescription drug costs in the United States continued to…

Since the onset of the COVID-19 pandemic in January 2020, the United States has recorded more than 32 million cases and nearly…

On April 30, 2021, the United States Department of Justice (DOJ) announced a $3.8 million settlement with CareCloud Health, Inc.,…

On May 13, 2021, the Centers for Medicare and Medicaid Services (CMS) issued an interim final rule with comment period, updating…

In the midst of the chaos in Washington, D.C. in January 2021, the United States Senate Finance Committee released the results of…

On April 13, 2021, the United States Court of Appeals for the Fifth Circuit denied a Petition for Review filed by Impax…